Validating the ODDI Disability Index in 205 Patients

November 11, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Reader question: How well did the ODDI capture both visible severity and functional disability in occupational hand dermatitis?

Study snapshot

Study element	Reported detail
Population	205 occupational-dermatology patients; 95 were assessed as having occupational contact dermatitis of the hands.
Design	Validation study assessing content and construct validity, intraobserver and interobserver reliability, internal consistency and usability.
Comparator	ODDI scores versus global clinical dermatology severity assessment and repeated ratings by observers.
Timepoint	Validation assessments after treatment or modified work duties; no long-term prognostic follow-up was reported.
Key result	ODDI correlated moderately with global clinical severity (r=.54, P≤.01). Intraobserver ICC was .62, interobserver ICC .75 and internal-consistency ICCs .94-.99.
Funding/conflict context	PubMed classifies the paper as non-US government-supported research; the XML lists no grant detail or conflict statement.

What was actually measured?

ODDI correlated moderately with global clinical severity (r=.54, P≤.01). Intraobserver ICC was .62, interobserver ICC .75 and internal-consistency ICCs .94-.99.

Moderate correlation supports construct validity without making the two measures interchangeable. Reliability estimates describe consistency, not whether the index predicts job loss or treatment response.

The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.

What the result does not prove

Only 95/205 had the target hand diagnosis, post-treatment or modified-duty context may narrow severity, and prognostic validity was not established.

Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.

Exposure detail matters more than the job label

Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.

A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.

Questions worth recording

Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
Where did the change begin, and did it improve on days away or after a process or PPE change?
How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
Were labels, ingredient information and safety-data sheets reviewed with occupational health?
Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?

Prevention comes before cosmetic care

Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.

Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.

Primary research and guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.

← Back to Doctor's Notes